Follow
Ingrid E. Fakkert
Ingrid E. Fakkert
Arts UWV
Verified email at uwv.nl
Title
Cited by
Cited by
Year
Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
JR Vos, IE Fakkert, JA de Hullu, AM van Altena, AS Sie, H Ouchene, ...
JNCI: Journal of the National Cancer Institute 112 (2), 161-169, 2020
612020
A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening
EH Gerkes, JM Fock, WFA den Dunnen, MJ van Belzen, CA van der Lans, ...
Neurogenetics 17, 83-89, 2016
512016
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer
IE Fakkert, EM Abma, IG Westrik, JD Lefrandt, BHR Wolffenbuttel, ...
European Journal of Cancer 51 (3), 400-408, 2015
372015
Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers
IE Fakkert, MJE Mourits, L Jansen, DM van der Kolk, K Meijer, ...
Cancer Prevention Research 5 (11), 1291-1297, 2012
352012
Bone mineral density and fractures after surgical menopause: systematic review and meta‐analysis
IE Fakkert, N Teixeira, EM Abma, RHJA Slart, MJE Mourits, GH de Bock
BJOG: An International Journal of Obstetrics & Gynaecology 124 (10), 1525-1535, 2017
242017
Evaluation of yield and experiences of age‐related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify …
JR Vos, IE Fakkert, L Spruijt, RW Willems, S Langenveld, ...
International journal of cancer 147 (8), 2150-2158, 2020
212020
Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy
IE Fakkert, L Jansen, K Meijer, T Kok, JC Oosterwijk, MJE Mourits, ...
Breast cancer research and treatment 129, 157-164, 2011
192011
Elevated bone turnover markers after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer
IE Fakkert, E Van Der Veer, EM Abma, JD Lefrandt, BHR Wolffenbuttel, ...
PloS one 12 (1), e0169673, 2017
142017
Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy
N Teixeira, MJ Mourits, JC Oosterwijk, IE Fakkert, AR Absalom, ...
Familial cancer 18, 19-27, 2019
92019
New multidisciplinary tasks in finding all Lynch Syndrome among patients with colorectal cancer below age 70
JR Vos, IE Fakkert, L Spruijt, RW Willems, S Langenveld, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 27, 1581-1581, 2019
2019
Tumour DNA BRCA1/2 testing in newly diagnosed ovarian cancer as pre-selection for PARP inhibitor therapy and germline testing is feasible and effective
N Hoogerbrugge, IE Fakkert, ID Nagtegaal, EM Leter, AR Mensenkamp, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 27, 453-453, 2019
2019
Raising the age limit for routine MMR testing in colorectal cancer from 50 to 70 years improves recognition of new Lynch syndrome families
N Hoogerbrugge, IE Fakkert, RW Willems, YK Peeks, S Langenveld, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 26, 90-91, 2018
2018
BRCA testing in ovarian tumors initiated by a pathologist: a pre-screen for germline testing and therapy choice
IE Fakkert, AR Mensenkamp, EM Leter, JA de Hullu, RW Willems, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 26, 528-529, 2018
2018
Beyond risk-reducing salpingo-oophorectomy: On breast cancer risk and bone health
IE Fakkert
2017
Beyond risk-reducing salpingo-oophorectomy
IE Fakkert
2017
Breast cancer screening in and mutation carriers after risk reducing salpingo-oophorectomy
IE Fakkert, L Jansen, K Meijer, T Kok, JC Oosterwijk, MJE Mourits, ...
Breast cancer screening in women with hereditary elevated risk for breast and ovarian cancer after prophylactic bilateral salpingo-oophorectomy
I Fakkert, VS Wetenschap
The system can't perform the operation now. Try again later.
Articles 1–17